Burning Rock Biotech Ltd

BNR

Company Profile

  • Business description

    Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

  • Contact

    No. 5, Xingdao Ring Road North
    International Bio Island
    Guangzhou510005
    CHN

    T: +86 2034037871

    https://www.brbiotech.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2026

    Employees

    667

Stocks News & Analysis

stocks

A better way to predict long-term stock returns

A value-weighted version of the CAPE ratio corrects a structural flaw and delivers stronger forecasts of long-term stock returns.
stocks

Five star stock added to August best ideas list

Morningstar analysts hand pick this undervalued opportunity for their August global best ideas.
stocks

Undervalued supermarket share sees sales improvement

Improving sales trends but recovery remains gradual.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,923.903.700.04%
CAC 408,100.8078.97-0.97%
DAX 4025,394.26174.30-0.68%
Dow JONES (US)52,573.29509.190.98%
FTSE 10010,711.1060.660.57%
HKSE24,917.60111.970.45%
NASDAQ26,333.04251.310.96%
Nikkei 22563,492.99518.35-0.81%
NZX 50 Index13,560.6919.64-0.14%
S&P 5007,656.980.000.00%
S&P/ASX 2008,749.908.700.10%
SSE Composite Index3,885.332.78-0.07%

Market Movers